首页> 外文期刊>Child Neurology Open >Clinical Phenotype of De Novo GNAO1 Mutation: Case Report and Review of Literature
【24h】

Clinical Phenotype of De Novo GNAO1 Mutation: Case Report and Review of Literature

机译:De Novo GNAO1突变的临床表型:病例报告和文献复习

获取原文
           

摘要

Mutations in the guanine nucleotide-binding protein (G protein), ?± activating activity polypeptide O (GNAO1) gene have recently been described in 6 patients with early infantile epileptic encephalopathies. In the present study, we report the phenotype and the clinical course of a 4-year-old female with an epileptic encephalopathy (Ohtahara syndrome) and profound intellectual disability due to a de novo GNAO1 mutation (c.692AG; p.Tyr231Cys). Ohtahara syndrome is a devastating early infantile epileptic encephalopathy that can be caused by mutations in different genes, now also including GNAO1. The mutation was found using a targeted next generation sequencing gene panel and demonstrates targeted sequencing as a powerful tool for identifying mutations in genes where only a few de novo mutations have been identified.
机译:最近在6例婴儿期癫痫性脑病患者中描述了鸟嘌呤核苷酸结合蛋白(G蛋白),α±活化活性多肽O(GNAO1)基因的突变。在本研究中,我们报告了一名4岁女性,患有癫痫性脑病(Ohtahara综合征)并因从新GNAO1突变(c.692A> G; p.Tyr231Cys )。 Ohtahara综合征是一种破坏性的早期婴儿癫痫性脑病,可能由不同基因的突变引起,现在也包括GNAO1。该突变是使用靶向的下一代测序基因组发现的,它证明了靶向测序是一种用于鉴定仅从头突变的基因的强大工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号